Opna Bio
Clinical-stage biopharmaceutical company
Opna Bio has raised €37M across 1 funding round from 3 investors, most recently a Series A round in Nov 2022. Based in Epalinges, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Epalinges, Switzerlandwww.opnabio.com ↗
Total raised
€37M
€36,986,568
Funding rounds
1
Investors
3
distinct backers
Active since
2022-11
latest 2022-11
Funding by year
EUR raised per yearOpna Bio — funding by year — interactive chart.
Data table
| Opna Bio — funding by year | |
|---|---|
| 2022 | €37M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-22 | Series A | €37M | Longitude Capital,Menlo Ventures,Northpond Ventures | View deal → |
Related news
- Opna Bio Raises $38M in Series A Financingfinsmes.com · 2022-11
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData